Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Inv. presentation
Employment agrmnt
|
|
TITAN PHARMACEUTICALS INC (TTNP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2023 |
4
| Lazar David E. (CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 37,500 shares
@ $0.9659, valued at
$36.2k
Bought 20,000 shares
@ $1.0033, valued at
$20.1k
|
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2022 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Acquired 51,021 shares
@ $0 |
|
| 01/05/2022 |
4
| Akers Joseph A (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.18, valued at
$11.8k
|
|
| 01/05/2022 |
4
| MACFARLANE M DAVID (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.18, valued at
$11.8k
|
|
| 01/05/2022 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.18, valued at
$11.8k
|
|
| 01/05/2022 |
4
| Beebe Katherine (President and COO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 55,000 options to buy
@ $1.18, valued at
$64.9k
|
|
| 01/05/2022 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 65,000 options to buy
@ $1.18, valued at
$76.7k
|
|
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Akers Joseph A (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.02, valued at
$100.5k
|
|
| 02/11/2021 |
4
| MACFARLANE M DAVID (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.02, valued at
$100.5k
|
|
| 02/11/2021 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.02, valued at
$100.5k
|
|
| 02/11/2021 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 150,000 options to buy
@ $4.02, valued at
$603k
|
|
| 06/07/2019 |
4
| Hallberg Dane (See Remarks) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 80,000 options to buy
@ $1.5, valued at
$120k
|
|
| 04/03/2019 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $1.75, valued at
$350k
|
|
| 04/03/2019 |
4
| BHONSLE SUNIL (President and CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $1.75, valued at
$350k
|
|
| 10/22/2018 |
4
| Recli Federico Seghi (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 200,000 shares
@ $0 |
|
| 09/26/2018 |
4
| Recli Federico Seghi (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 500,000 shares
@ $0 |
|
| 09/25/2018 |
4
| MACFARLANE M DAVID (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 80,000 shares
@ $0.25, valued at
$20k
Granted 80,000 warrants
@ $0.25, valued at
$20k
|
|
| 09/25/2018 |
4
| BHONSLE SUNIL (See Remarks) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 300,000 shares
@ $0.25, valued at
$75k
Granted 300,000 warrants
@ $0.25, valued at
$75k
|
|
| 09/25/2018 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 200,000 shares
@ $0.25, valued at
$50k
Granted 200,000 warrants
@ $0.25, valued at
$50k
|
|
| 09/25/2018 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 400,000 shares
@ $0.25, valued at
$100k
Granted 400,000 warrants
@ $0.25, valued at
$100k
|
|
| 09/25/2018 |
4
| Akers Joseph A (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 200,000 shares
@ $0.25, valued at
$50k
Granted 200,000 warrants
@ $0.25, valued at
$50k
|
|
| 03/09/2018 |
4
| BHONSLE SUNIL (President and CEO) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 170,000 options to buy
@ $0.97, valued at
$164.9k
|
|
| 03/09/2018 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 170,000 options to buy
@ $0.97, valued at
$164.9k
|
|
| 09/19/2017 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.5, valued at
$15k
|
|
| 09/19/2017 |
4
| MCNAB JAMES R (Director) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 10,000 options to buy
@ $1.5, valued at
$15k
|
|
|
|
|